Bicarbonate

Bicarbonate

SCHEMBL7607307

CO.N.O=C(O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL5068363 1.00
Bicarbonate SCHEMBL4447985 0.94
Bicarbonate SCHEMBL29519185 0.94
Bicarbonate SCHEMBL27603254 0.94 CA1 (0.71)
Bicarbonate SCHEMBL28358443 0.88 CA1 (0.62)
Bicarbonate SCHEMBL10477709 0.88
Bicarbonate SCHEMBL28623473 0.88 CA1 (0.62)
Bicarbonate SCHEMBL4424344 0.88
Bicarbonate SCHEMBL13519489 0.88
Bicarbonate SCHEMBL28099673 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118258919-A Method for detecting farnesyl pyrophosphate and geranylgeranyl pyrophosphate in biological sample 华南农业大学 2024-06-28 CN claimed
CN-111024843-B Combined marker for diagnosing Parkinson's disease and detection kit 大连医科大学附属第一医院 2022-06-21 CN claimed
CN-112198233-B Combined marker and kit for diagnosis of retinopathy in diabetic patients DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2021-08-31 CN claimed
CN-112198233-A Combined marker and kit for diagnosis of retinopathy in diabetic patients 中国科学院大连化学物理研究所 2021-01-08 CN claimed
CN-104777242-B Associating mark, test kit and system for diagnosis of polycystic ovary syndrome 中国科学院大连化学物理研究所 2016-08-17 CN claimed
CN-104777242-A Combined markers, kit and system for diagnosis of polycystic ovarian syndrome DALIAN CHEMICAL PHYSICS INST 2015-07-15 CN claimed
CN-114887456-B Ammonium bicarbonate crystallization prevention system for low-temperature methanol washing process 蒲城清洁能源化工有限责任公司 2024-07-23 CN disclosed
CN-118258919-A Method for detecting farnesyl pyrophosphate and geranylgeranyl pyrophosphate in biological sample 华南农业大学 2024-06-28 CN disclosed
CN-111024843-B Combined marker for diagnosing Parkinson's disease and detection kit 大连医科大学附属第一医院 2022-06-21 CN disclosed
US-20220002265-A1 RHO KINASE INHIBITOR, METHOD FOR PREPARING SAME AND USES THEREOF BEIJING INCREASE INNOVATIVE DRUG CO., LTD (CN) 2022-01-06 US disclosed
CN-113777178-A Proteomics background library based on mixed spectrogram library, and construction method and application thereof 复旦大学 2021-12-10 CN disclosed
EP-3878846-A1 RHO KINASE INHIBITOR, METHOD FOR PREPARING SAME AND USES THEREOF Beijing Increase Innovative Drug Co., Ltd. (CN) 2021-09-15 EP disclosed
CN-112198233-B Combined marker and kit for diagnosis of retinopathy in diabetic patients DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2021-08-31 CN disclosed
CN-104364658-B For the method for diagnosing chronic valve disease 雀巢产品技术援助有限公司 2017-06-30 CN disclosed
CN-104777242-B Associating mark, test kit and system for diagnosis of polycystic ovary syndrome 中国科学院大连化学物理研究所 2016-08-17 CN disclosed
CN-104777242-A Combined markers, kit and system for diagnosis of polycystic ovarian syndrome DALIAN CHEMICAL PHYSICS INST 2015-07-15 CN disclosed
CN-103529139-B Method for analyzing metabolism difference of transgenic rice by using natural variation UNIV SHANGHAI JIAOTONG 2015-03-11 CN disclosed
CN-103529139-A Method for analyzing metabolism difference of transgenic rice by using natural variation UNIV SHANGHAI JIAOTONG 2014-01-22 CN disclosed
WO-2002081630-A2 USE OF SEMENOGELIN IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-10-17 WO disclosed
US-6342765-B1 COMPOUNDS THAT INHIBIT FARNESYLATION OF MUTANT RAS GENE PRODUCTS; TREATING DISEASES, ESPECIALLY CANCER, WHICH ARE MEDIATED THROUGH FARNESYLATION OF RAS ASTRAZENECA UK LIMITED (GB) 2002-01-29 US disclosed